Having spent the better part of my professional career nurturing relationships between big pharma and academia, it’s interesting to observe that there are still areas which are underserved. Case in point, the medical device industry is increasingly finding value in the halls of academia, especially those with powerhouse engineering departments. But who has time to walk the halls looking for PIs who may or may not be open to industry collaboration?
Chris Yochim
Chris is a leader in the Greater Philadelphia Life Science Community, promoting industry and academic collaborations to drive innovative science toward commercialization for the benefit of patients. He retired in 2015 after 35 years with ICI/Zeneca & AstraZeneca and is currently Head of Business Development for NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals) based at The Biotech Institute at the University of Delaware.
Recent Posts
AUTM, Academia and The MedTech Conference powered by AdvaMed
Posted by
Chris Yochim on March 14, 2018